Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians. OBJECTIVE: To review the randomized controlled trials (RCTs) and systematic reviews related to the pharmacological management of NeP to develop a revised evidence‐based consensus statement on its management. METHODS: RCTs, systematic reviews and existing guidelines on the pharmacological management of NeP were evaluated at a consensus meeting in May 2012 and updated until September 2013. Medications were recommended in the consensus statement if their analgesic efficacy was supported by at least one methodologically sound RCT (class I or class II) showing significant benefit relative to placebo or another relevant control group. Recommendations for treatment were based on the degree of evidence of analgesic efficacy, safety and ease of use. RESULTS: Analgesic agents recommended for first‐line treatments are gabapentinoids (gabapentin and pregabalin), tricyclic antidepressants and serotonin noradrenaline reuptake inhibitors. Tramadol and controlled‐release opioid analgesics are recommended as second‐line treatments for moderate to severe pain. Cannabinoids are now recommended as third‐line treatments. Recommended fourth‐line treatments include methadone, anticonvulsants with lesser evidence of efficacy (eg, lamotrigine, lacos‐amide), tapentadol and botulinum toxin. There is support for some analgesic combinations in selected NeP conditions. CONCLUSIONS: These guidelines provide an updated, stepwise approach to the pharmacological management of NeP. Treatment should be individualized for each patient based on efficacy, side‐effect profile and drug accessibility, including cost. Additional studies are required to examine head‐to‐head comparisons among analgesics, combinations of analgesics, long‐term outcomes and treatment of pediatric, geriatric and central NeP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Results from both the scientific literature and public media revealed few references to nabilone abuse.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, nabilone theft did occur, although nabilone has no known street value.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“According to the literature, the positive side effects (euphoria, mood elevation) of nabilone, which may lead to abuse, generally occurred less frequently than the negative side effects (drowsiness, dizziness, and dry mouth).”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the public media, patients described nabilone as not producing the same therapeutic and recreational effects as smoked cannabis.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Overall, the authors concluded that nabilone is rarely abused or diverted.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., Cunin, G., Fermanian, J., Ginies, P., Grun-Overdyking, A., et al. (2005) · Pain · doi:10.1016/j.pain.2004.12.010 · Cited by 2,741
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy
Max, M. B., Lynch, S. A., Muir, J., Shoaf, S. E., Smoller, B., & Dubner, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261904 · Cited by 1,117
The evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Smith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N., et al. (2013) · JAMA · doi:10.1001/jama.2013.2813 · Cited by 1,014
Torrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Research works printed but not linked: 1
- [20]Cohen J Statistical Power Analysis for the Behavioural Sciences New York, San Francisco, London Academic Press 1988
Cited by
Items 301–400 of 529
Metabotropic Glutamate Receptor 5: A Potential Target for Neuropathic Pain Treatment
Manengu, C., Zhu, C., Zhang, G., Tian, M., Lan, X., Tao, L., Ma, L., Liu, Y., Yu, J., & Liu, N. (2024) · Current Neuropharmacology · doi:10.2174/1570159x23666241011163035 · Cited by 8
Bélanger, L. M., Umedaly, H. S., Noonan, V. K., Park, S. E., Prince, J., Thorogood, N. P., Shen, T., Townson, A. F., Street, J., Dvorak, M. F., et al. (2017) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000523 · Cited by 6
Hoshina, Y., Wong, K., Galli, J. R., Bacharach, R., Klein, J., Lebiedz‐Odrobina, D., ROSE, J. W., Trump, B., Hull, C. M., Greenlee, J., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1174116 · Cited by 9
Imafuku, S., Korematsu, K., Mori, N., Kani, T., & Matsui, K. (2023) · The Journal of Dermatology · doi:10.1111/1346-8138.16876 · Cited by 6
Tarasiuk, A., Mirocha, G., & Fichna, J. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01146-4 · Cited by 6
Symptom management in the older adult- 2015 Update
Smith, T. J. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.01.006 · Cited by 6
Sicras‐Mainar, A., Rejas, J., Pérez‐Páramo, M., & Navarro‐Artieda, R. (2016) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12634 · Cited by 6
Sicras‐Mainar, A., Rejas, J., Pérez‐Páramo, M., & Navarro‐Artieda, R. (2018) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0008 · Cited by 6
Polypharmacy and Rational Prescribing: Changing the Culture of Medicine One Patient at a Time
Yoon, S. K., Okyere, B., & Strasser, D. C. (2019) · Current Physical Medicine and Rehabilitation Reports · doi:10.1007/s40141-019-00220-z · Cited by 7
Vozoris, N., Yao, Z., Li, P., Austin, P., Stephenson, A., Gill, S., O'Donnell, D., Gershon, A., & Rochon, P. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00707-3 · Cited by 6
Calling for Openness to the Study of Cannabis Use in Chronic Pelvic Pain
Manz, J., Hyakutake, M., & Kelly, E. (2020) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2020.08.021 · Cited by 6
Buffon, A. C., JAVORNIK, M. A., Heymanns, A. C., Salm, D. C., Horewicz, V. V., Martins, D. F., & Piovezan, A. P. (2020) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202020191155 · Cited by 6
Small Fiber Neuropathy in the Elderly
Zhou, L. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.01.002 · Cited by 7
Plancarte-Sánchez, R., Samano-García, M., Guillén-Núñez, M. D. R., & Equihua-Ortega, A. (2021) · Gaceta Médica de México · doi:10.24875/gmm.m21000562 · Cited by 7
Hidayati, H. B., Machfoed, M. H., Kuntoro, K., Subadi, I., Khaerunnisa, S., & Widjiati, W. (2021) · Anaesthesia Pain & Intensive Care · doi:10.35975/apic.v25i1.1441 · Cited by 7
Gilron, I., DeBow, C., Elkerdawy, H., Khan, J. S., Salomons, T. V., Duggan, S., Tu, D., Holden, R. R., Milev, R. V., Buckley, D. N., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087180 · Cited by 6
Self-citationTran, R. T., Patil, A. S., Nguyen, P. P., Nguyen, G. H., Qadeer, A., Chen, G. H., Govindaraj, R., & Hasoon, J. J. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4510 · Cited by 5
Antidepressant drugs for neuropathic pain - an overview of Cochrane reviews
Moore, A., Kalso, E. A., Wiffen, P. J., Derry, S., Tölle, T. R., Finnerup, N. B., Attal, N., & Lunn, M. P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011606.pub2 · Cited by 5
Kochi, T., Nakamura, Y., Ma, S., Uemoto, S., Hisaoka‐Nakashima, K., Irifune, M., & Morioka, N. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113829 · Cited by 5
Cannabinoids—Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series
Graczyk, M., Lewandowska, A. A., Melnyczok, P., Zgliński, A., & Łukowicz, M. (2022) · Biomedicines · doi:10.3390/biomedicines10081862 · Cited by 7
Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy
Farkas, D. J., Cooper, Z. D., Heydari, L. N., Hughes, A. C., Rawls, S. M., & Ward, S. J. (2025) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0064 · Cited by 6
Lü, F., Zhong, J., Liu, H., & Xiao, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1258464 · Cited by 5
Pharmacological Management of Neuropathic Pain: Current Trends and Possible Approaches
Kumar, A., Pottabathini, R., Bhatnagar, A., Garg, S., & Gupta, V. (2016) · Archives of Neuroscience · doi:10.5812/archneurosci.28998 · Cited by 7
Anticonvulsants in the Treatment of Pain
Li, C. T., & Watson, J. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-12281-2_19 · Cited by 5
de Barros, G. A. M., Pos, A. M., Sousa, Â. M., Pereira, C. L., Nobre, C. D. D. A., Palmeira, C. C. D. A., Caruy, C. A. A., Munhoz, D. C., Kraychete, D. C., Bergamaschi, E. C. Q. A., et al. (2024) · Brazilian Journal of Anesthesiology (English Edition) · doi:10.1016/j.bjane.2024.844513 · Cited by 8
Zhang, C., Wu, Z., Fan, W., Wei, W., Mutallip, M., Yang, S., Zhao, W., Sun, Y., & Chen, X. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115936 · Cited by 4
Mental Health in Burn Survivors
Bergeron, N., Bond, S., & Boyle, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-39193-5_11 · Cited by 5
State of the science: cannabis and cannabinoids in palliative medicine—the potential
Roychoudhury, P., Kapoor, A. K., Walsh, D., Cortés, H., & Clarke, H. A. (2021) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2021-002888 · Cited by 6
Self-citationOdonkor, C. A., AlFarra, T., Adekoya, P., Orhurhu, V., Rodríguez, T., Sottosanti, E., & Kaye, A. D. (2022) · Current Pain and Headache Reports · doi:10.1007/s11916-022-01008-y · Cited by 5
Looking Back, Moving Forward in Pain Medicine
Paladini, A., Gharibo, C. G., Khalbous, S., Salti, A., Ergönenç, T., Pasqualucci, A., & Varrassi, G. (2023) · Cureus · doi:10.7759/cureus.44716 · Cited by 5
Lee, J., Philip, K., Wijeysundera, D. N., Clarke, H. A., Pritlove, C., Katz, J. D., Ritvo, P., Goel, A., Husain, M. I., & Ladha, K. S. (2024) · Canadian Journal of Pain · doi:10.1080/24740527.2024.2406285 · Cited by 5
Self-citationDisagreements between Medical Specialty Boards and their Diplomates
Waisel, D. B. (2015) · The AMA Journal of Ethic · doi:10.1001/journalofethics.2015.17.3.spec1-1503 · Cited by 4
Pharmacologic Management of Upper Extremity Chronic Nerve Pain
Carroll, I. R. (2015) · Hand Clinics · doi:10.1016/j.hcl.2015.08.011 · Cited by 4
Kohli, S., Sharma, T., Kalra, J., & Dhasmana, D. C. (2016) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20160078 · Cited by 4
Chahine, B., & Souheil, F. A. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00398-x · Cited by 4
Afonso, A. S., Siguero, A. N., Mosquera, E. P., Mazarro, D. O., Mateos, R. G., & Hernández, C. P. (2021) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2021.3911/2021 · Cited by 4
Synthetic cannabinoid for the treatment of severe chronic noncancer pain in children and adolescents
Sun, N., Cunha, N., Amar, S., & Brown, S. (2022) · Canadian Journal of Pain · doi:10.1080/24740527.2022.2132138 · Cited by 9
Xú, G., Tang, W., Zhou, C., Xu, J., Cheng, C., Gong, W., Dong, S., & Zhang, Y. (2023) · Journal of Pain Research · doi:10.2147/jpr.s404713 · Cited by 4
Valenzuela‐Fuenzalida, J. J., López-Chaparro, M., Barahona-Vásquez, M., Campos-Valdes, J., Gonzalez, J. C., Nova-Baeza, P., Orellana‐Donoso, M., Suazo-Santibáñez, A., Oyanedel-Amaro, G., & Gutiérrez‐Espinoza, H. (2024) · Pharmaceuticals · doi:10.3390/ph17070856 · Cited by 6
Laparoscopic treated neuralgia after inguinal hernia repair: case report and literature review
Engelen, M. M., Dilen, K., & Baten, E. (2017) · Acta chirurgica Belgica · doi:10.1080/00015458.2017.1354437 · Cited by 4
Central Post Stroke Pain: The Clinical-Anatomical Correlations from Pain Clinic Stories
Ščiupokas, A. (2018) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2018.11.002133 · Cited by 4
Treatment of Brachial Plexus Injuries
Vanaclocha, V., & Sáiz‐Sapena, N. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.71238 · Cited by 4
Poli‐Neto, O. B., Chamochumbi, C. C. M., Toscano, P., Julio, M. P., Marques, W., Rosa‐e‐Silva, J., Candido-dos-Reis, F. J., & Nogueira, A. (2018) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15204 · Cited by 4
EFFICACY AND SAFETY OF GABAPENTIN AND PREGABALIN IN CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Manjushree, N., Chakraborty, A., & Shashidhar, V. K. (2021) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2021.v14i1.39978 · Cited by 4
Pain management in cervical cancer
Rosas, S. A., Plancarte, R., Hernández-Porras, B. C., García-Andreu, J., Velazquez, B. O. L., Reyes, I., & Alarcón-Barrios, S. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1371779 · Cited by 3
Therapeutic use of cannabinoids in age-related pain: Current evidence and clinical perspectives
Pulone, S., Moulton, C., Nucera, S., Ilari, S., Muscoli, C., & Tasciotti, E. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108130 · Cited by 4
Herrarte, C., Martinez, M. A., Gonzalvo, J. D., Davis, B. T., Thoma, L. M., & Campbell, N. L. (2024) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2024.102113 · Cited by 3
Moatamed, R. S., Khajavinia, A., Barzegar, S., Purves, R. W., Laprairie, R. B., & El‐Aneed, A. (2024) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.9952 · Cited by 4
Gabapentin Use in Postoperative and Neuropathic Pain in Children
Buck, M. L. (2016) · Cited by 3
Jin, Q., Li, W., Chu, X., & Huang, L. (2022) · Cellular and Molecular Biology · doi:10.14715/cmb/2021.67.6.18 · Cited by 3
Henares, J. F. G., & Moraga, J. D. S. (2022) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2022.4024/2022 · Cited by 4
Zhang, Z., Zhao, Y. S., Du, T.-Y., Zhang, J., Wu, Q., & Wang, Z. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1122538 · Cited by 3
A perspective on a precision approach to pain in cancer; moving beyond opioid therapy
Chang, P. J., Amaral, L. J., Asher, A., Clauw, D. J., Jones, B., Thompson, P. A., & Warner, A. S. (2023) · Disability and Rehabilitation · doi:10.1080/09638288.2023.2212916 · Cited by 7
Reaume, J. (2023) · Canadian Journal of Pain · doi:10.1080/24740527.2023.2228851 · Cited by 5
Review of the cardiovascular toxicity of amitriptyline treatment for canine neuropathic pain
Sutayatram, S., Soontornvipart, K., & Glangosol, P. (2018) · The Thai Journal of Veterinary Medicine · doi:10.56808/2985-1130.2943 · Cited by 2
Neuropathic Pain Management, Pharmacological Approaches, Neuromodulation and Quality of Life
Ali, B., Alqubaishi, R., Asiri, F., Alkhadhrawi, M., Aldhohayan, A., Aljabri, F. M. S., Alahmari, A., Alharbi, R., Altowairqi, M., Alshawaf, R., et al. (2023) · doi:10.52533/johs.2023.31232 · Cited by 2
Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder
Roy, B. D., Li, J., Lally, C. A., Akerman, S. C., Sullivan, M. A., Fratantonio, J. L., Flanders, W. D., & Wenten, M. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05676-5 · Cited by 3
Wang, Z., Wang, J., Qin, L., & Zhang, W. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/8197281 · Cited by 3
Nano-carriers for Natural Therapeutics in Management of Neuropathic Pain
Nigam, K., Ruba, P. H., Kapoor, P., Gabrani, R., & Dang, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-41858-8_16 · Cited by 3
Neurogastroenterology in Spinal Cord Dysfunction
Holmes, G. M., Hudson, T. R., & Filart, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-46293-6_16 · Cited by 4
Sollie, M., & Sørensen, J. A. (2018) · British Journal of Pain · doi:10.1177/2049463718817570 · Cited by 3
Cost-effectiveness of mirogabalin for the treatment of post-herpetic neuralgia in Taiwan
Ye, X., Gray, E., Wang, Y.-F., & Wang, S. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2020.1720694 · Cited by 3
Maschio, M. C. E., Mengarelli, A., Zarabla, A., Giannarelli, D., Maialetti, A., Gumenyuk, S., Renzi, D., Palombi, F., Pisani, F., Romano, A., et al. (2019) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000360 · Cited by 3
Cannabis en el tratamiento del dolor crónico no oncológico
Evelyn Muñoz, S. (2015) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2015.71526 · Cited by 10
Placebo response in chronic peripheral neuropathic pain trials: systematic review and meta-analysisPreprint
Duarte, G. S., Mainoli, B., Rodrigues, F. B., Rato, F., Machado, T. L. G. N., Ferreira, J. J., & Costa, J. (2022) · medRxiv · doi:10.1101/2022.02.18.22271196 · Cited by 4
Sangolli, P. M., & George, N. M. (2024) · Clinical Dermatology Review · doi:10.4103/cdr.cdr_132_22 · Cited by 2
Huang, K.-H., Wang, T.-H., Tsai, T., Gau, S., Su, K.-Y., Huang, S.-W., Chang, Y.-L., & Lee, C. (2026) · Pain · doi:10.1097/j.pain.0000000000003906 · Cited by 2
Marijuana and Cannabinoids for Pain
Furnish, T. J., & Wallace, M. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-30964-4_7 · Cited by 2
Substance Use Disorders in Late Life
DeVido, J. J., Hirsch, C. H., Sanger, N., Rosic, T., Samaan, Z., & Bourgeois, J. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-67555-8_16 · Cited by 3
Vicente, J. A. G., Urgell, C. V., Fernández, R. V., Rodríguez, D. R., Noguerola, S. R., & Bernal, D. S. (2019) · Atención Primaria · doi:10.1016/j.aprim.2019.09.001 · Cited by 2
The role of cannabinoids in the management of symptoms in palliative care patients
Graczyk, M., & Leppert, W. (2021) · Palliative Medicine in Practice · doi:10.5603/pmpi.2021.0016 · Cited by 3
Glial-modulating agents for the treatment of pain: protocol for a systematic review
Gilron, I., Xiao, M. Z. X., Balanaser, M., Carley, M. E., Ghasemlou, N., Salter, M. W., Hutchinson, M. R., Moulin, D. E., Moore, A., & Ross‐White, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055713 · Cited by 2
Self-citationDüzenli, N., Can, C., & Önal, A. (2022) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2022.00030 · Cited by 3
Heydarirad, G., Mirzaei, H. R., Gharehgozlou, R., Büntzel, J., Namazi, M. R., & Pasalar, M. (2024) · Indian Journal of Palliative Care · doi:10.25259/ijpc_32_2023 · Cited by 2
Felemban, A., Allan, S., Youssef, E., Verma, R., & Zehtabchi, S. (2024) · European Journal of Emergency Medicine · doi:10.1097/mej.0000000000001158 · Cited by 2
Li, J.-L., Zhu, C., Tian, M., Liu, Y., Ma, L., Tao, L., Zheng, P., Yu, J., & Liu, N. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.10.004 · Cited by 2
Other Psychiatric Disorders, Psychosocial Factors, Sleep, and Pain
Bair, M. J., & Owen‐Smith, A. A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197675250.003.0006 · Cited by 5
Seta, R. R., Mahabadi, S. E., Delphi, L., Alijanpour, S., & Rezayof, A. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.067 · Cited by 2
Mesa-Pérez, J. A., Odriozola, A., Antonucci, R., Campillo, N., Márquez, G., Gil, J. C., Ziegler, D., Hernández, S., Faget, O., Davidson, J. A., et al. (2019) · Alad · doi:10.24875/alad.19000376 · Cited by 3
Utilidad de la desvenlafaxina en dolor crónico
Montero, A. A., & Curado, A. G. (2016) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2016.3448/2016 · Cited by 2
Safety differentiation: emerging competitive edge in drug development
Uteng, M., Urbán, L., Brees, D., Muller, P. Y., Kullak-Ublick, G. A., Bouchard, P. R., Tougas, G. H., & Chibout, S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.009 · Cited by 3
Situación actual de Cannabis sativa, beneficios terapéuticos y reacciones adversas
Rodríguez-Venegas, E. D. L. C., & Fontaine-Ortiz, J. E. (2020) · Revista Habanera de Ciencias Médicas · Cited by 9
Bhatia, A., Bril, V., Brull, R., Perruccio, A. V., Wijeysundera, D. N., Lau, J., Gandhi, R. A., Mahomed, N. N., & Davis, A. M. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000945 · Cited by 2
Suponeva, N. A., Белова, Н. В., Zaitseva, N. I., Yusupova, D. G., Lagoda, D. Y., Korepina, O. S., & Пирадов, М. А. (2017) · Annals of Clinical and Experimental Neurology · doi:10.18454/acen.2017.1.6169 · Cited by 8
Évolution des pratiques en médecine générale dans la prise en charge des douleurs neuropathiques
Poucher, M., Cherrier, C., Poucher, A.-C., & Patrizio, P. D. (2016) · Santé Publique · doi:10.3917/spub.164.0505 · Cited by 2
Cannabinoids in chronic pain management: a skein to be untangled
Coluzzi, F. (2018) · Minerva Anestesiologica · doi:10.23736/s0375-9393.18.12701-5 · Cited by 2
Antidepressant drugs for neuropathic pain - an overview of Cochrane reviews
Moore, A., Kalso, E. A., Wiffen, P. J., Derry, S., Tölle, T. R., Finnerup, N. B., Attal, N., & Lunn, M. P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011606 · Cited by 2
RetractedDiordiev, A. V., & Vl, A. (2019) · Annals of critical care · doi:10.21320/1818-474x-2019-1-36-44 · Cited by 1
Role of HDAC5 Epigenetics in Chronic Craniofacial Neuropathic Pain
Hui, S. E., & Westlund, K. N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136889 · Cited by 3
Moatamed, R. S., Laprairie, R. B., & El‐Aneed, A. (2025) · Mass Spectrometry Reviews · doi:10.1002/mas.70005 · Cited by 1
Cannabis-based extract for managing pain in dogs with osteoarthritis: efficacy and safety assessment
Griebeler, N. M., Cremonese, R. P., Fakih, Y. R. C., Pereira, P. R. M., Rial, A. F., Leite, E., Gonçalves, M. V. L., Almas, L. R. M. D., Cardoso, N. B., Cezar‐dos‐Santos, F., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1539704 · Cited by 1
Liu, Y., Ji, H., Bai, S. W., Tian, X., Zhang, W., & Jia, G. A. (2026) · Nursing Open · doi:10.1002/nop2.70539 · Cited by 1
Waggan, A. I., Imtiaz, K., Ayo-Farai, O., Okwilagwe, H., Ehi-Iyoha, I., Akhtar, R., Oduoye, M. O., & Naseer, M. Q. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1903334 · Cited by 1
Treatment of Pain with Antidepressants
Kerr, B. J., Benson, C. A., Mifflin, K. A., Jesudasan, S. J. B., Dursun, S. M., & Baker, G. B. (2015) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20150825014707 · Cited by 2
El dolor en el síndrome de Guillain - Barré ¿un síntoma subtratado?
Granada, U. M. N., Gutiérrez, J. B. H., Arenas, F. A. L., de Cancerología, I. N., Portillo, A. M. A., & de Cancerología, I. N. (2015) · Revista Colombiana de Medicina Física y Rehabilitación · doi:10.28957/rcmfr.v25n2a7 · Cited by 1
Composition of Canadian Pain Society guideline development group?
Lexchin, J. (2018) · Europe PMC (PubMed Central) · Cited by 1
Gabapentin and pregabalin in the pain setting: All you need to know
Rees, S. (2018) · Nurse Prescribing · doi:10.12968/npre.2018.16.7.332 · Cited by 1
A 53-Year-Old Woman with Pain, Burning, Tingling, and Numbness in the Distal Limbs
Zhou, L. (2019) · Springer eBooks · doi:10.1007/978-3-030-25682-1_39 · Cited by 1
The role of pregabalin in neuropathic pain management in cancer patients
Jakubów, P., Kościuczuk, U., Kosel, J., Soroko, P., Kondracka, J., & Tałałaj, M. (2020) · Palliative Medicine in Practice · doi:10.5603/pmpi.2020.0020 · Cited by 2
THE NEUROPATHIC COMPONENT OF PAIN SYNDROME IN OSTEOARTHRITIS
Саварина, В. А. (2018) · Health and Ecology Issues · doi:10.51523/2708-6011.2018-15-3-2 · Cited by 1
Metadata
- Authors
- Moulin, D., Boulanger, A., Clark, A., Clarke, H., Dao, T., Finley, G., Furlan, A., Gilron, I., Gordon, A., Morley-Forster, P., Sessle, B., Squire, P., Stinson, J., Taenzer, P., Velly, A., Ware, M., Weinberg, E., & Williamson, O.
- Affiliations
- Victoria Hospital (CA)
- Corresponding author
- Moulin, DE
- Venue
- Pain Research and Management
- Publisher
- Wiley
- Published
- 2014-01
- Volume
- 19
- Issue
- 6
- Pages
- 328-335
- ISSN
- 1203-6765 (ISSN-L)
- 1918-1523
- PMC
- PMC4273712
- OpenAlex
- W2206489433
- Cited by
- 529
- References
- 97
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 54 · 2023: 38 · 2022: 38 · 2021: 58 · 2020: 53 · 2019: 53 · 2018: 52 · 2017: 60 · 2016: 50 · 2015: 43
- FWCI
- 34.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pain Research and Management (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship@McGill (McGill) (submittedVersion, cc-by)
- eScholarship@McGill (McGill) (submittedVersion, other-oa)
- Funders
- Neuropathic Pain Special Interest Group of the CPS
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- neuropathic pain, pharmacological management, gabapentinoids, pregabalin, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, tramadol, controlled-release opioids, cannabinoids, methadone, antiepileptic drugs, tapentadol, botulinum toxin, analgesic combination, stepwise treatment, analgesic efficacy and safety
- MeSH terms
- Analgesics, Canada, Humans, Neuralgia, Chronic Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.